Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- Geriatrics Program Moves Up to No. 8, Primary Care Debuts on U.S.News & World Report's “Best Graduate Schools”
The geriatrics program at the University of Arkansas for Medical Sciences (UAMS) has moved from No. 9 to No. 8, ahead of Yale University, in the annual ranking of “America's Best Graduate Schools” by the news magazine, U. S. News & World Report.
- Historic Pharmacy Artifacts in New Library Exhibit
APRIL 9, 2004 | A collection of antique patent medicines and related paper goods, photographs and advertisements will be on display in the UAMS Library through June 30.
- Historic Pharmacy Artifacts in New Library Exhibit
APRIL 9, 2004 | A collection of antique patent medicines and related paper goods, photographs and advertisements will be on display in the UAMS Library through June 30.
- Historic Pharmacy Artifacts in New Library Exhibit
APRIL 9, 2004 | A collection of antique patent medicines and related paper goods, photographs and advertisements will be on display in the UAMS Library through June 30.
- UAMS Honors Donald E. McMillan for 26 Years
APRIL 16, 2004 | The University of Arkansas for Medical Sciences (UAMS) honored Donald E. McMillan, Ph.D., April 9 for building the Department of Pharmacology and Toxicology of the UAMS College of Medicine into one of the leading research and educational programs in the nation in that field.
- Jones Eye Institute Celebrates 10 Years of Success
APRIL 23, 2004 | “Double Vision” was the theme April 22 for the 10th anniversary celebration of the University of Arkansas for Medical Science’s (UAMS) Harvey and Bernice Jones Eye Institute. Former U.S. Senator Dale Bumpers was the keynote speaker at the event where special tribute was paid to the “foresight” of Springdale philanthropists Pat Walker and the late Bernice Jones, two “simply remarkable women” whose support of the Eye Institute and UAMS has been “transforming.”
- Jones Eye Institute Celebrates 10 Years of Success
APRIL 23, 2004 | “Double Vision” was the theme April 22 for the 10th anniversary celebration of the University of Arkansas for Medical Science’s (UAMS) Harvey and Bernice Jones Eye Institute. Former U.S. Senator Dale Bumpers was the keynote speaker at the event where special tribute was paid to the “foresight” of Springdale philanthropists Pat Walker and the late Bernice Jones, two “simply remarkable women” whose support of the Eye Institute and UAMS has been “transforming.”
- Jones Eye Institute Celebrates 10 Years of Success
APRIL 23, 2004 | “Double Vision” was the theme April 22 for the 10th anniversary celebration of the University of Arkansas for Medical Science’s (UAMS) Harvey and Bernice Jones Eye Institute. Former U.S. Senator Dale Bumpers was the keynote speaker at the event where special tribute was paid to the “foresight” of Springdale philanthropists Pat Walker and the late Bernice Jones, two “simply remarkable women” whose support of the Eye Institute and UAMS has been “transforming.”
- Annual “Career Day” Attracts Students Interested in Science Careers
MAY 3, 2004 | Future scientists from across Arkansas recently gathered at the University of Arkansas for Medical Sciences (UAMS) with one common goal – to learn more about what the future might hold for them.
- Annual “Career Day” Attracts Students Interested in Science Careers
MAY 3, 2004 | Future scientists from across Arkansas recently gathered at the University of Arkansas for Medical Sciences (UAMS) with one common goal – to learn more about what the future might hold for them.
- ACRC Auxiliary’s Annual Cooks Tour Raises More than $50,000 for Family Home; Ronda Henry Tillman, M.D., Is Honored with Special Award
MAY 3, 2004 | It was the perfect way to spend a Sunday afternoon – enjoying delicious food prepared by some of Little Rock’s finest chefs and touring four beautiful homes in the Sologne area of Chenal Valley as the Arkansas Cancer Research Center (ACRC) Auxiliary held its annual Cooks Tour fund-raiser, April 25.
- ACRC Auxiliary’s Annual Cooks Tour Raises More than $50,000 for Family Home; Ronda Henry Tillman, M.D., Is Honored with Special Award
MAY 3, 2004 | It was the perfect way to spend a Sunday afternoon – enjoying delicious food prepared by some of Little Rock’s finest chefs and touring four beautiful homes in the Sologne area of Chenal Valley as the Arkansas Cancer Research Center (ACRC) Auxiliary held its annual Cooks Tour fund-raiser, April 25.
- ACRC Auxiliary’s Annual Cooks Tour Raises More than $50,000 for Family Home; Ronda Henry Tillman, M.D., Is Honored with Special Award
MAY 3, 2004 | It was the perfect way to spend a Sunday afternoon – enjoying delicious food prepared by some of Little Rock’s finest chefs and touring four beautiful homes in the Sologne area of Chenal Valley as the Arkansas Cancer Research Center (ACRC) Auxiliary held its annual Cooks Tour fund-raiser, April 25.
- ACRC Auxiliary’s Annual Cooks Tour Raises More than $50,000 for Family Home; Ronda Henry Tillman, M.D., Is Honored with Special Award
MAY 3, 2004 | It was the perfect way to spend a Sunday afternoon – enjoying delicious food prepared by some of Little Rock’s finest chefs and touring four beautiful homes in the Sologne area of Chenal Valley as the Arkansas Cancer Research Center (ACRC) Auxiliary held its annual Cooks Tour fund-raiser, April 25.
- UAMS Partners With ACH to Install State’s First Endowed Chair in Pediatric Nursing
May 7, 2004 | Much is expected of Bonnie Gance-Cleveland, Ph.D., R.N.C., P.N.P., B.C., but she’s used to coming through for those in need. Especially when its young people dealing with a drug-addicted parent, obesity or violence.
- Fighting Diabetes in Rural Arkansas
May 17, 2004 | People with diabetes find that their health improves once they have been trained to manage their disease.
- Fighting Diabetes in Rural Arkansas
May 17, 2004 | People with diabetes find that their health improves once they have been trained to manage their disease.
- Fighting Diabetes in Rural Arkansas
May 17, 2004 | People with diabetes find that their health improves once they have been trained to manage their disease.
- Barlogie Receives Distinction for Career of Fighting Myeloma
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
- Barlogie Receives Distinction for Career of Fighting Myeloma
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
- Barlogie Receives Distinction for Career of Fighting Myeloma
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
- Barlogie Receives Distinction for Career of Fighting Myeloma
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
- UAMS Neurosurgeon Receives Award Close to His Heart
June 7, 2004 | The first time Sam Al-Mefty, M.D., became interested in a type of brain tumor caused by radiation was when he met fellow neurosurgeon Steven Mahaley, M.D., in Saudi Arabia.
- New Dean of UAMS Graduate School Has Big Plans for the Future
McGehee says he wants to “razzle-dazzle” prospective UAMS graduate students. Recruiting potential students is just one of the goals he hopes to accomplish as the new dean of the University of Arkansas for Medical Sciences (UAMS) Graduate School.
- New Dean of UAMS Graduate School Has Big Plans for the Future
McGehee says he wants to “razzle-dazzle” prospective UAMS graduate students. Recruiting potential students is just one of the goals he hopes to accomplish as the new dean of the University of Arkansas for Medical Sciences (UAMS) Graduate School.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Medical Students Spend Summer Days Helping At-Risk Youth
JUNE 25, 2004 | Summer means a lot of things to different people, but for many college students it means relaxing by the pool, playing at the lake and enjoying not having to wake up early for classes. But for a group of medical students from the University of Arkansas for Medical Sciences (UAMS), summer means something entirely different – the chance to help underprivileged youth.
- UAMS Medical Students Spend Summer Days Helping At-Risk Youth
JUNE 25, 2004 | Summer means a lot of things to different people, but for many college students it means relaxing by the pool, playing at the lake and enjoying not having to wake up early for classes. But for a group of medical students from the University of Arkansas for Medical Sciences (UAMS), summer means something entirely different – the chance to help underprivileged youth.
- U.S.News & World Report Names UAMS Among Best Hospitals
LITTLE ROCK – For the ninth consecutive year, UAMS Medical Center has been named by U.S.News & World Report to its annual list of “America’s Best Hospitals,” moving up four places from last year. UAMS is the only hospital in the state named to the list.
- U.S.News & World Report Names UAMS Among Best Hospitals
LITTLE ROCK – For the ninth consecutive year, UAMS Medical Center has been named by U.S.News & World Report to its annual list of “America’s Best Hospitals,” moving up four places from last year. UAMS is the only hospital in the state named to the list.
- U.S.News & World Report Names UAMS Among Best Hospitals
LITTLE ROCK – For the ninth consecutive year, UAMS Medical Center has been named by U.S.News & World Report to its annual list of “America’s Best Hospitals,” moving up four places from last year. UAMS is the only hospital in the state named to the list.
- U.S.News & World Report Names UAMS Among Best Hospitals
LITTLE ROCK – For the ninth consecutive year, UAMS Medical Center has been named by U.S.News & World Report to its annual list of “America’s Best Hospitals,” moving up four places from last year. UAMS is the only hospital in the state named to the list.
- Aubrey Hough, 2004 Distinguished Faculty Scholar, Talks Bioterrorism
AUG. 2, 2004 | Aubrey J. Hough, M.D., traced the use of bioterrorism through the ages in his lecture as the 2004 UAMS Distinguished Faculty Scholar. Hough, recently appointed Associate Dean for Translational Research and Special Projects, continues to focus his energies on initiating research programs in biodefense as well as the re-engineering of UAMS’ clinical research infrastructure.
- Aubrey Hough, 2004 Distinguished Faculty Scholar, Talks Bioterrorism
AUG. 2, 2004 | Aubrey J. Hough, M.D., traced the use of bioterrorism through the ages in his lecture as the 2004 UAMS Distinguished Faculty Scholar. Hough, recently appointed Associate Dean for Translational Research and Special Projects, continues to focus his energies on initiating research programs in biodefense as well as the re-engineering of UAMS’ clinical research infrastructure.
- Aubrey Hough, 2004 Distinguished Faculty Scholar, Talks Bioterrorism
AUG. 2, 2004 | Aubrey J. Hough, M.D., traced the use of bioterrorism through the ages in his lecture as the 2004 UAMS Distinguished Faculty Scholar. Hough, recently appointed Associate Dean for Translational Research and Special Projects, continues to focus his energies on initiating research programs in biodefense as well as the re-engineering of UAMS’ clinical research infrastructure.
- Transplant Surgeon to Help Launch the State’s First Liver Transplant Program at UAMS
AUG. 9, 2004 | Establishing a liver transplant program is nothing new to You Min Wu, M.D. Not only did he initiate a liver transplant program at an Iowa hospital, but he also introduced liver transplantation to his native country of China. Now, he will help launch the state’s first liver transplant program at the University of Arkansas for Medical Sciences (UAMS).
- Transplant Surgeon to Help Launch the State’s First Liver Transplant Program at UAMS
AUG. 9, 2004 | Establishing a liver transplant program is nothing new to You Min Wu, M.D. Not only did he initiate a liver transplant program at an Iowa hospital, but he also introduced liver transplantation to his native country of China. Now, he will help launch the state’s first liver transplant program at the University of Arkansas for Medical Sciences (UAMS).
- James Marsh, Internal Medicine Chair, Settles into New Job and State
AUG. 23, 2004 | Almost two months into his position as the new chair of the Department of Internal Medicine at the University of Arkansas for Medical Sciences (UAMS), James D. Marsh, M.D., says Arkansas is treating him well.
- James Marsh, Internal Medicine Chair, Settles into New Job and State
AUG. 23, 2004 | Almost two months into his position as the new chair of the Department of Internal Medicine at the University of Arkansas for Medical Sciences (UAMS), James D. Marsh, M.D., says Arkansas is treating him well.
- Freshmen White Coat Ceremony Imparts Importance of Integrity
AUG. 24, 2004 | The University of Arkansas for Medical Sciences (UAMS) held its White Coat Ceremony for freshmen College of Medicine students this month at the Robinson Center Exhibition Hall.
- Freshmen White Coat Ceremony Imparts Importance of Integrity
AUG. 24, 2004 | The University of Arkansas for Medical Sciences (UAMS) held its White Coat Ceremony for freshmen College of Medicine students this month at the Robinson Center Exhibition Hall.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- UAMS ANGELS Prenatal Program Receives National Innovation Award
SEPT. 2, 2004 | ANGELS, a University of Arkansas for Medical Sciences (UAMS) program to improve regional prenatal care for high-risk pregnancies, has attracted national attention for its innovation.
- UAMS ANGELS Prenatal Program Receives National Innovation Award
SEPT. 2, 2004 | ANGELS, a University of Arkansas for Medical Sciences (UAMS) program to improve regional prenatal care for high-risk pregnancies, has attracted national attention for its innovation.
- DeBartolo York Foundation Gift Establishes Hough Endowed Chair in Pathology at UAMS
Sept. 13, 2004 | The Marie Denise DeBartolo York Foundation has made a gift of $1.5 million to the University of Arkansas for Medical Sciences (UAMS) to establish the Aubrey J. Hough Jr., M.D., Endowed Chair in Pathology and the John and Denise DeBartolo York Chief Residency in Pathology.
- DeBartolo York Foundation Gift Establishes Hough Endowed Chair in Pathology at UAMS
Sept. 13, 2004 | The Marie Denise DeBartolo York Foundation has made a gift of $1.5 million to the University of Arkansas for Medical Sciences (UAMS) to establish the Aubrey J. Hough Jr., M.D., Endowed Chair in Pathology and the John and Denise DeBartolo York Chief Residency in Pathology.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Looks to Future Hospital, Growth, Chancellor Says in Annual State of the Campus Address
SEPT. 27, 2004 | Chancellor I. Dodd Wilson, M.D., proclaimed the University of Arkansas for Medical Sciences (UAMS) healthy and ready for the challenge of building a replacement for its 50-year-old hospital during his annual state of the campus speech Tuesday.
- UAMS Looks to Future Hospital, Growth, Chancellor Says in Annual State of the Campus Address
SEPT. 27, 2004 | Chancellor I. Dodd Wilson, M.D., proclaimed the University of Arkansas for Medical Sciences (UAMS) healthy and ready for the challenge of building a replacement for its 50-year-old hospital during his annual state of the campus speech Tuesday.
- UAMS Fitness Center Kicks Off with an Aerobic Celebration
Oct. 8, 2004 | Hearts were pumping and feet were moving at the recent opening of the new University of Arkansas for Medical Sciences (UAMS) Fitness Center – and that was before the exercising even began.
- UAMS Fitness Center Kicks Off with an Aerobic Celebration
Oct. 8, 2004 | Hearts were pumping and feet were moving at the recent opening of the new University of Arkansas for Medical Sciences (UAMS) Fitness Center – and that was before the exercising even began.
- UAMS celebrates opening of Westside Campus in historic district
OCT. 14, 2004 | The University of Arkansas for Medical Sciences (UAMS) Department of Pediatrics marked the opening of its new Westside Campus at 1301 Wolfe St. in Little Rock with a recent open house at the facility, which is located in the former West Side Junior High School.
- UAMS celebrates opening of Westside Campus in historic district
OCT. 14, 2004 | The University of Arkansas for Medical Sciences (UAMS) Department of Pediatrics marked the opening of its new Westside Campus at 1301 Wolfe St. in Little Rock with a recent open house at the facility, which is located in the former West Side Junior High School.
- UAMS celebrates opening of Westside Campus in historic district
OCT. 14, 2004 | The University of Arkansas for Medical Sciences (UAMS) Department of Pediatrics marked the opening of its new Westside Campus at 1301 Wolfe St. in Little Rock with a recent open house at the facility, which is located in the former West Side Junior High School.
- UAMS surgeon performs successful implant of heart pump in child at ACH
OCT. 15, 2004 | Jonathan Drummond-Webb, M.D., chief of pediatric cardiovascular surgery and associate professor of surgery at the University of Arkansas for Medical Sciences (UAMS) College of Medicine and chief of pediatric cardiovascular surgery at Arkansas Children’s Hospital (ACH), led a surgical team that recently implanted a child with a newly developed miniature heart pump. The teen-ager, the second to receive the heart pump, is now the longest survivor after receiving the device.
- UAMS surgeon performs successful implant of heart pump in child at ACH
OCT. 15, 2004 | Jonathan Drummond-Webb, M.D., chief of pediatric cardiovascular surgery and associate professor of surgery at the University of Arkansas for Medical Sciences (UAMS) College of Medicine and chief of pediatric cardiovascular surgery at Arkansas Children’s Hospital (ACH), led a surgical team that recently implanted a child with a newly developed miniature heart pump. The teen-ager, the second to receive the heart pump, is now the longest survivor after receiving the device.
- UAMS surgeon performs successful implant of heart pump in child at ACH
OCT. 15, 2004 | Jonathan Drummond-Webb, M.D., chief of pediatric cardiovascular surgery and associate professor of surgery at the University of Arkansas for Medical Sciences (UAMS) College of Medicine and chief of pediatric cardiovascular surgery at Arkansas Children’s Hospital (ACH), led a surgical team that recently implanted a child with a newly developed miniature heart pump. The teen-ager, the second to receive the heart pump, is now the longest survivor after receiving the device.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
The international award is presented annually to researchers who have made major contributions in the field of basic or clinical oncology. O’Brien recently received the award at the 32nd annual meeting of the International Society for Oncodevelopmental Biology and Medicine (ISOBM) in Helsinki, Finland, on June 22.
“I feel very humbled by the award,” said O’Brien, “but I would like to believe that it translates into more important improvements for women’s health and well-being and more ways to treat women with cancer.”
O’Brien said he doesn’t deserve all the credit for the award. “No one person can do this,” he said. “There are a large number of contributors who have helped what has happened with ovarian cancer research in the last 30 years. Many of them are my colleagues and research group here at UAMS, and I’ve also collaborated with groups in Japan, Sweden and Norway.”
O’Brien began studying women’s cancers in the 1960s and began focusing on ovarian cancer in the 1970s at the University of Southern California. In 1984, O’Brien joined UAMS and in 1997 founded UAMS Arkansas BioVentures, a biotechnology business accelerator that converts UAMS research into jobs for Arkansans.
O’Brien and his team are now researching ways to better detect ovarian cancer in its earliest stages. “Ovarian cancer is a major killer of women, and it’s clear that one of the issues surrounding ovarian cancer is diagnosis,” he said. “At this time, we diagnose women at Stage 3 of the cancer, when it has already spread. This happens in 75 percent of the cases. What we would like to do is move the diagnosis from Stages 3 and 4 to Stages 1 and 2. Eventually, we hope to cure women by early diagnosis.”
He explained that ovarian cancer is hard to diagnose because it grows without any significant symptoms, which is why it’s often referred to as the “silent killer.”
One of O’Brien’s most notable accomplishments in ovarian cancer research is his discovery that a gene known as CA125 can identify the presence of ovarian cancer cells in women. His work was patented – the first patent ever for UAMS – and was licensed to a large biotechnology company in Pennsylvania. The company marketed a CA125 diagnostic kit, which is now the most commonly used test for ovarian cancer around the world.
Two years ago, O’Brien and his team successfully cloned the complex CA125 gene. “This allows us to look at this molecule in a different way so that we can continue to improve ways of testing for ovarian cancer,” O’Brien said.
“As the population grows older in the United States, testing for ovarian cancer will become more important,” he said. O’Brien said approximately one in 17 women in Arkansas will have ovarian cancer.
O’Brien said he hopes that eventually doctors and gynecologists will use the CA125 diagnostic kit to test for ovarian cancer as routinely as they perform pap smears. “Ultimately, we hope that women can use home tests for ovarian cancer,” he said.
O’Brien is the author of more than 70 peer reviewed articles and book chapters and is the associate editor of the journal, Tumor Biology. He is on the advisory board for the Institute of Food Science and Engineering, where he provides direction for multidisciplinary research in biotechnology and agricultural medicine; a board member of Safe Foods Corporation; and founder of the Arkansas Biotechnology Association.
Links on this page:
Department of Obstetrics and Gynecology: http:www.uams.edu/obgyn/
UAMS Arkansas BioVentures: http://www.uamsbiotech.com/default.asp
© 2004 University of Arkansas for Medical Sciences (UAMS). A single copy of these materials may be reprinted for noncommercial personal use only. “UAMS,” “UAMS Medical Center,” “UAMS Online,” “UAMS Today,” “UAMS Update,” “uams.edu,” and “Here’s to Your Health” are marks of UAMS. |